HDAC inhibitors (Merck & Co/WuXi AppTec)

N/A

Report date: 2025/03/20 14:45:07
NME

Base Information

Drug NameHDAC inhibitors (Merck & Co/WuXi AppTec)
Drug Alias Namehistone deacetylase inhibitors (Merck & Co/WuXi AppTec)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsHistone deacetylase 2 inhibitorsHistone deacetylase 3 inhibitors +[5] 
TargetsHistone deacetylase 2Histone deacetylase 1Histone deacetylase 6 +[5] 
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMerck Sharp & Dohme LLC
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLCWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A